Samrat Pharmachem Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 549.41 million compared to INR 351.909 million a year ago. Net income was INR 15.359 million compared to INR 4.711 million a year ago. Basic earnings per share from continuing operations was INR 4.97 compared to INR 1.52 a year ago. For the nine months, total revenue was INR 1,317.468 million compared to INR 1,076.692 million a year ago. Net income was INR 37.734 million compared to INR 38.436 million a year ago. Basic earnings per share from continuing operations was INR 12.21 compared to INR 12.44 a year ago.